REQUEST A DEMO
Total
USD $0.00
Search more companies

Edis Pharma Ilac San. Ve Tic. Ltd. Sti. (Turkiye)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Edis Pharma Ilac Sanayi Ve Ticaret Limited Sirketi Profile Updated: November 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Edis Pharma Ilac San. Ve Tic. Ltd. Sti. is based in Turkiye. The head office is in Istanbul. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on February 24, 2015. The total number of employees is currently 120 (2025). There was a net sales revenue increase of 30.46% reported in Edis Pharma Ilac San. Ve Tic. Ltd. Sti.’s latest financial highlights for 2024. During that time, Edis Pharma Ilac San. Ve Tic. Ltd. Sti.’s total assets grew by 43.6%.

Headquarters
No:11-1 Cumhuriyet Mahallesi Cumhuriyet Caddesi Cekmekoy
Istanbul; Marmara; Postal Code: 34788

Contact Details: Purchase the Edis Pharma Ilac San. Ve Tic. Ltd. Sti. report to view the information.

Website: http://www.edispharma.com.tr

Basic Information
Total Employees:
Purchase the Edis Pharma Ilac San. Ve Tic. Ltd. Sti. report to view the information.
Financial Auditors:
Purchase the Edis Pharma Ilac San. Ve Tic. Ltd. Sti. report to view the information.
Incorporation Date:
February 24, 2015
Key Executives
Purchase this report to view the information.
Company Manager
Company Performance
Financial values in the chart are available after Edis Pharma Ilac San. Ve Tic. Ltd. Sti. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
30.46%
Total operating revenue
30.46%
Operating profit (EBIT)
-36%
Net Profit (Loss) for the Period
N/A
Total assets
43.6%
Total equity
-9.87%
Operating Profit Margin (ROS)
-5.66%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
91.17%
Quick Ratio
-0.31%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?